- June 10-11, 2026
- Virtual
Tumor genomics, epigenetics, and proteomics
Cancer stem cells and tumor heterogeneity
Metastasis and recurrence mechanisms
Microbiome and cancer progression
Novel biomarkers for early detection
Immunotherapy advancements (CAR-T, bispecific antibodies, checkpoint inhibitors)
Targeted therapies (KRAS inhibitors, CDK4/6 inhibitors, antibody-drug conjugates)
Chemotherapy resistance and precision oncology
Radiotherapy advancements (proton therapy, FLASH radiotherapy, AI-driven dose optimization)
AI-driven drug discovery and predictive modeling
Lifestyle interventions (diet, exercise, smoking cessation)
Liquid biopsies and AI-powered diagnostics
Vaccines for cancer prevention (HPV, hepatitis B, mRNA-based cancer vaccines)
Population-specific screening guidelines and disparities
Environmental and occupational carcinogens
Long-term toxicities (cardio-oncology, neurocognitive impact, financial toxicity)
Rehabilitation strategies (exercise oncology, prosthetics, virtual reality for pain management)
Mental health, psychosocial support, and survivorship care models
Digital health tools for monitoring and patient engagement
Palliative care innovations and integrative medicine
Breast Cancer: HER2+, TNBC, AI in mammography, survivorship disparities
Lung Cancer: Early detection, EGFR/ALK inhibitors, environmental factors
Prostate Cancer: PSMA-targeted therapies, active surveillance, racial disparities
Colorectal Cancer: Rising incidence in young adults, microbiome interactions, Lynch syndrome
Hematologic Malignancies: CAR-T for leukemia/multiple myeloma, MRD monitoring
Rare & Neglected Cancers: Sarcomas, mesothelioma, cholangiocarcinoma, orphan drug development
Access to cancer care in LMICs and underserved regions
Cost-effective treatment strategies and chemotherapy shortages
Cultural barriers to cancer education and screening
Gender disparities and stigmatized cancers
Cancer care in crisis settings (war zones, pandemics, refugee populations)
AI/ML in imaging, diagnostics, and pathology
Big data and predictive analytics for treatment response
Robotics and minimally invasive cancer surgeries
Telemedicine and virtual clinical trials
Blockchain for secure patient data sharing
Genomic data privacy and international data-sharing regulations
Equity in clinical trials (elderly, disabled, minority representation)
CRISPR and gene editing ethics
AI bias and fairness in oncology decision-making
Drug pricing, healthcare policy reforms, and patient advocacy
Cancer risks from microplastics, air pollution, and radiation exposure
Circadian disruption and shift work-related cancer risks
Obesity, nutrition, and the microbiome’s role in cancer progression
Climate change and its impact on cancer incidence
Workplace and occupational carcinogens
Organ preservation techniques and intraoperative imaging
Robotic-assisted and minimally invasive surgeries
AI-guided radiotherapy planning and optimization
Personalized radiation therapy (FLASH radiotherapy, adaptive radiation)
Multidisciplinary approaches to complex surgical cases
National and global cancer control initiatives (WHO, NCI, etc.)
Patient advocacy and engagement in treatment decision-making
Drug patent waivers and access to affordable cancer treatments
Ethical concerns in AI, genetic testing, and telemedicine
Environmental carcinogens and regulatory frameworks
Funding and career development opportunities for young researchers
Translational research success stories and case studies
Science communication, grant writing, and industry-academia collaborations
Innovation challenges and pitch competitions (AI, digital health, bioengineering)
Mentorship and networking sessions with senior researchers
With over 500+ researchers from 30+ countries, G-CARE 2026 highlights underrepresented voices and groundbreaking discoveries — A Summit Without Borders
Driving equitable cancer research through global collaboration and innovation and bridging borders to accelerate cancer care solutions for all.
© 2020-2026 Organized by VYYOMA INTENRATIONAL
